Advanced Therapy Medicinal Products CDMO Market is expected to display a steady growth of 14% due to the rise in research & development activities | UnivDatos Market Insights
NOIDA, India, March 21, 2023 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Advanced Therapy Medicinal Products CDMO Market was valued at more than USD 4 billion in 2021 and is expected to grow at a CAGR of around 14% from 2022-2028. The analysis has been segmented into Product (Gene Therapy, Cell Therapy, Tissue Engineered, and Others); Phase (Phase I, Phase II, Phase III, and Phase IV); Indication (Oncology, Cardiology, Central Nervous System, Musculoskeletal, Infectious Disease, and Others); and Region/Country.
Click here to view the Report Description & TOC
https://univdatos.com/report/advanced-therapy-medicinal-products-cdmo- ...
The advanced therapy medicinal products CDMO market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the advanced therapy medicinal products CDMO market. The advanced therapy medicinal products CDMO market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the advanced therapy medicinal products CDMO market at the global and regional levels.
Request for Sample Pages
https://univdatos.com/get-a-free-sample-form-php/?product_id=36028
Market Overview
Advanced Therapy Medicinal Products (ATMPs) are a new category of medicines that offer innovative treatments for various diseases and medical conditions. They include cell and gene therapies, tissue-engineered products, and other innovative treatments. The Contract Development and Manufacturing Organizations (CDMO) market for ATMPs provides services for the development and manufacturing of ATMPs, helping companies bring their products to market more quickly and cost-effectively.
The market for ATMPs is growing rapidly, driven by the increasing demand for new and effective treatments for various diseases and conditions, including cancer, genetic disorders, and chronic diseases such as diabetes and heart disease. The market is further driven by advancements in biotechnology and the increasing availability of cutting-edge technologies and the increasing demand for new and effective treatments for rare genetic diseases and conditions, the market is expected to continue growing in the coming years. For instance, as per the United States Center for Disease Control and Prevention article on spinal muscular atrophy (SMA) updated in December 2021, SMA is a genetic disorder that affects around 1 in every 10,000 people. Therefore, it is one of the most common rare diseases.